| Literature DB >> 33087782 |
Michele Veldsman1,2, Emilio Werden3, Natalia Egorova3,4, Mohamed Salah Khlif3, Amy Brodtmann3,5,6.
Abstract
Executive dysfunction affects 40% of stroke patients, but is poorly predicted by characteristics of the stroke itself. Stroke typically occurs on a background of cerebrovascular burden, which impacts cognition and brain network structural integrity. We used structural equation modelling to investigate whether measures of white matter microstructural integrity (fractional anisotropy and mean diffusivity) and cerebrovascular risk factors better explain executive dysfunction than markers of stroke severity. 126 stroke patients (mean age 68.4 years) were scanned three months post-stroke and compared to 40 age- and sex-matched control participants on neuropsychological measures of executive function. Executive function was below what would be expected for age and education level in stroke patients as measured by the organizational components of the Rey Complex Figure Test, F(3,155) = 17, R2 = 0.25, p < 0.001 (group significant predictor at p < 0.001) and the Trail-Making Test (B), F(3,157) = 3.70, R2 = 0.07, p < 0.01 (group significant predictor at p < 0.001). A multivariate structural equation model illustrated the complex relationship between executive function, white matter integrity, stroke characteristics and cerebrovascular risk (root mean square error of approximation = 0.02). Pearson's correlations confirmed a stronger relationship between executive dysfunction and white matter integrity (r = - 0.74, p < 0.001), than executive dysfunction and stroke severity (r = 0.22, p < 0.01). The relationship between executive function and white matter integrity is mediated by cerebrovascular burden. White matter microstructural degeneration of the superior longitudinal fasciculus in the executive control network better explains executive dysfunction than markers of stroke severity. Executive dysfunction and incident stroke can be both considered manifestations of cerebrovascular risk factors.Entities:
Mesh:
Year: 2020 PMID: 33087782 PMCID: PMC7578057 DOI: 10.1038/s41598-020-75074-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Patient and control demographics at the 3 month time-point.
| Demographics | Statistics | Group difference | |
|---|---|---|---|
| Stroke patients | Healthy controls | ||
| Number (female) | 135(41) | 40(15) | Chi Square X2 = 0.72, |
| Mean age (SD) | 68 (11.8) | 69 (6.6) | Welch’s t(120) = 0.26, |
| Right handed:Left handed | 125:10 | 36:4 | Chi Square X2 = 0.28, |
| Median years of education (IQR 1,3) | 12 (10,15) | 17 (11,18) | Mann–Whitney w = 3689, |
| Mean MoCA (SD) | 23 (4.1) | 26 (2.2) | Welch’s t(119) = 4.99, |
| Median NIHSS (IQR 1,3) | 0 (0,1) | – | Change in NIHSS baseline-3 months, Wilcoxon Signed Rank test z = 4437, |
| Median mRS (IQR 1,3) | 1 (1,2) | – | – |
| Median CVR Score (IQR 1,3) | 2 (2,4) | 1 (1,2) | Mann–Whitney w = − 1712, |
| Body Mass Index (% > 30 kg/m2/2) | 30 | 18 | – |
| Percent diagnosed/medicated hypertension | 63 | 43 | – |
| Percent diagnosed/medicated hypercholesteremia | 46 | 35 | – |
| Percent with type II diabetes | 34 | 10 | – |
| Percent with ischaemic heart disease | 25 | 0.03 | – |
| Percent diagnosed atrial fibrillation | 24 | 0.03 | – |
| Percentage of smokers | 47 | 33 | – |
| Percent drinking > 14 units alcohol per week | 10 | 18 | – |
| Mean stroke lesion volume in mm3 (SD) | 7979 (13,810) | – | – |
| Mean white matter hyperintensity volume mm3 (SD) | 19 (8.3) | 10 (2.7) | Welch’s t(145) = − 9.78, |
| Mean fractional anisotropy in superior longitudinal fasciculus (SD) | 0.43 (0.04) | 0.46 (0.01) | Welch’s t(144) = 6.52, |
| Mean mean diffusivity in the superior longitudinal fasciculus (cube transformed)(SD) | 0.08 (0.002) | 0.08 (0.00001) | Welch’s t(134) = − 5.52, |
Group demographics at three month timepoint.
IQR, interquartile range; SD, standard deviation; MoCA, Montreal Cognitive Assessment; CVR, cerebrovascular risk score; NIHSS, National Institute of Health Stroke Scale; mRS, Modified Rankin Scale.
Figure 1Lesion overlap map. Lesion overlap map displayed on Montreal Neurological Institute template. Colorbar indicates maximum number of overlapping lesions.
Figure 2Executive dysfunction in stroke patients compared to age-matched controls. Boxplots displaying performance (z-score) in stroke patients compared to age-matched controls in three tests of executive function, the Rey Complex Figure task (left panel), Trail Making Test B (middle panel), Clock Drawing task (right panel).
Figure 3Structural equation path models. Values in square indicators are R2. Values on paths are standardized beta estimates. (a) Full path model. (b) Model constrains the contribution of frontoparietal white matter integrity of the superior longitudinal fasciculus for nested model testing. Red paths show positive directional relationships, blue paths show negative relationships. Black arrows indicate covariances. *paths significant to p < 0.05.
Figure 4Scatterplots showing latent variable relationships with executive impairment. Correlation between executive impairment and (a) a latent variable representing stroke severity and (b) a latent variable representing white matter integrity of the superior longitudinal fasciculus.
Figure 5Mediation analysis. Mediation analyses of the relationship between executive impairment and frontoparietal white matter integrity mediated by (a) cerebrovascular risk (CVR) and (b) stroke severity. *path significant to p < 0.05, **p < 0.001. Value in brackets indicates the standardized beta estimate of the indirect path.